WO2024201385 - COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND KILLER CELLS
National phase entry:
Publication Number
WO/2024/201385
Publication Date
03.10.2024
International Application No.
PCT/IB2024/053054
International Filing Date
28.03.2024
Title **
[English]
COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND KILLER CELLS
[French]
COMPOSITIONS, SYSTÈMES ET MÉTHODES DE TRAITEMENT DU CANCER À L'AIDE DE CHAMPS DE TRAITEMENT DE TUMEURS ET DE CELLULES TUEUSES
Applicants **
NOVOCURE GMBH
Inventors
KAN, Tal
BARSHESHET, Yiftah
Priority Data
63/493,141
30.03.2023
US
63/599,142
15.11.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2308 | |
| EPO | Filing, Examination, Granting | 10951 | |
| Japan | Filing, Examination, Granting | 2309 | |
| South Korea | Filing, Examination, Granting | 2418 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,726
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Compositions, systems, and methods for reducing viability of cancer cells and treating cancer, as well as preventing an increase of volume of a tumor present in a body of a living subject, are disclosed. The systems and methods involve application of an alternating field concurrently with administration of at least one composition comprising at least one killer cell (such as, but not limited to, at least one natural killer (NK) cell or at least one cytokine‐induced killer (CIK) cell).[French]
La divulgation concerne des compositions, des systèmes et des méthodes pour réduire la viabilité de cellules cancéreuses et traiter le cancer, ainsi que pour prévenir une augmentation du volume d'une tumeur présente dans le corps d'un patient vivant. Les systèmes et les méthodes impliquent l'application d'un champ alternatif simultanément avec l'administration d'au moins une composition comprenant au moins une cellule tueuse (telle que, mais sans y être limitée, au moins une cellule tueuse naturelle (NK) ou au moins une cellule tueuse induite par cytokine (CIK)).